Tenon Medical, Inc. Financing Cash Flow
Tenon Medical, Inc. (TNON) reported Financing Cash Flow of $3.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Tenon Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- Tenon Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.87M, a 38.22% decline year-over-year.
- Tenon Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.73M, a 2315.93% increase year-over-year.
- Tenon Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $59.00K, a 99.39% decline year-over-year.
- Tenon Medical, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $8.99M, a 36.36% decline from fiscal 2024.
- Tenon Medical, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $14.13M, a 124.14% increase from fiscal 2023.
- Tenon Medical, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $6.30M, a 55.35% decline from fiscal 2022.
- Tenon Medical, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $14.11M, a 23.06% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.87M 10-Q · filed 2026-08-13 | $6.60M derived: sum of 3 quarters · filed 2026-08-13 | $6.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $3.87M 10-Q · filed 2026-05-15 | $6.60M derived: sum of 2 quarters · filed 2026-05-15 | $6.66M derived: sum of 3 quarters · filed 2026-05-15 | $6.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.79M derived: sum of 2 quarters · filed 2026-03-27 | $2.73M derived: sum of 3 quarters · filed 2026-08-13 | $8.99M 10-K · filed 2026-03-27 |
| 2025-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $6.26M 10-Q · filed 2025-11-13 | $6.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $6.20M 10-Q · filed 2026-08-13 | $6.31M derived: sum of 3 quarters · filed 2026-08-13 | $15.95M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.26M 10-Q · filed 2026-05-15 | $6.37M derived: sum of 2 quarters · filed 2026-05-15 | $16.01M derived: sum of 3 quarters · filed 2026-05-15 | $16.01M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $9.75M derived: sum of 2 quarters · filed 2026-03-27 | $9.75M derived: sum of 3 quarters · filed 2026-03-27 | $14.13M 10-K · filed 2026-03-27 |
| 2024-09-30 | $9.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.64M derived: sum of 2 quarters · filed 2025-11-13 | $14.01M 10-Q · filed 2025-11-13 | $15.38M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $4.37M 10-Q · filed 2025-08-13 | $5.74M derived: sum of 3 quarters · filed 2025-08-13 | $6.01M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $4.37M 10-Q · filed 2025-05-13 | $5.74M derived: sum of 2 quarters · filed 2025-05-13 | $6.01M derived: sum of 3 quarters · filed 2025-05-13 | $10.71M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $1.64M derived: sum of 2 quarters · filed 2025-03-26 | $6.34M derived: sum of 3 quarters · filed 2025-03-26 | $6.30M 10-K · filed 2025-03-26 |
| 2023-09-30 | $266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.97M derived: sum of 2 quarters · filed 2024-11-14 | $4.93M 10-Q · filed 2024-11-14 | $4.91M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.67M 10-Q · filed 2024-08-13 | $4.64M derived: sum of 3 quarters · filed 2024-08-13 | $4.64M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$42.00K 10-Q · filed 2024-05-15 | -$67.00K derived: sum of 2 quarters · filed 2024-05-15 | -$67.00K derived: sum of 3 quarters · filed 2024-05-15 | $14.13M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$25.00K derived: sum of 2 quarters · filed 2024-03-29 | $14.17M derived: sum of 3 quarters · filed 2024-03-29 | $14.11M 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $14.19M derived: sum of 2 quarters · filed 2023-11-14 | $14.14M 10-Q · filed 2023-11-14 | $13.96M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $14.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $14.14M 10-Q · filed 2023-08-11 | $13.96M derived: sum of 3 quarters · filed 2023-08-11 | $17.75M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$54.00K 10-Q · filed 2023-05-09 | -$233.00K derived: sum of 2 quarters · filed 2023-05-09 | $3.55M derived: sum of 3 quarters · filed 2023-05-09 | $11.45M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $3.61M derived: sum of 2 quarters · filed 2023-03-10 | $11.50M derived: sum of 3 quarters · filed 2023-03-10 | $11.47M 10-K · filed 2023-03-10 |
| 2021-09-30 | $3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $11.68M derived: sum of 2 quarters · filed 2022-11-10 | $11.65M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $7.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $7.86M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$30.00K 10-Q · filed 2022-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |